MSF and the Mini-Lab team were present at the 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), which took place in Lisbon, Portugal from 23 to 26 April 2022.
Dr Nada Malou's intervention at the DIHAD 2022 conference
DIHAD is considered the first humanitarian and development event in the Middle East and has been bringing together leading humanitarian actors, government emergency management agencies, foundations and others since 2004. On the occasion of the 18th conference held from March 14-16, 2022, Dr Nada Malou presented Antibiogo.
The MSF Foundation is innovating by adapting a tool to help healthcare workers manage diabetic ketoacidosis, a severe acute complication in children with diabetes.
In 2025, the Antibiogo application is seeing wide deployment, extending beyond MSF field operations. After being adopted by all MSF laboratories in 2024, the tool has also been integrated...
Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in children (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial
Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial